Delivery Order SPE2DB24D1104-SPE2DB24FXVW4
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,329.89 firm fixed price delivery order is for the pharmaceutical product Orgovyx 120 mg tablet, with a completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,329.89 firm fixed price delivery order is for the provision of the pharmaceutical product Orgovyx 120 mg tablet, with a period of performance through June 13, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range...
- This firm fixed price delivery order worth $3,989.67 was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for Orgovyx 120 mg tablets and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract is for the medication Orgovyx 120 mg tablet, with a completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the prescription drug Orgovyx 120 mg tablets. The contract has a ceiling value of $1,329.89 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This is a delivery order award to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,329.89, is for the pharmaceutical product Orgovyx 120 mg Tablet. The contract has a firm fixed price and is not associated with any set-aside designation. Amerisourcebergen Drug Corporation serves as the prime contractor and is the recipient of multiple federal contract awards from the DLA,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,385.52, is a Firm Fixed Price Delivery Order for Orgovyx 120 mg tablets. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a Delivery Order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, valued at $1,329.89, is for the delivery of the pharmaceutical product ORGOVYX 120 MG TABLET. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $3,989.67 Firm Fixed Price Delivery Order is for the supply of the prescription medication ORGOVYX 120 MG TABLET, with a performance period ending on July 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,385.52, is for the supply of the prescription medication Orgovyx (relugolix) 120 mg tablets. The award has an ultimate completion date of May 29, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB24FXVW4Delivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,989.67 contract is for the delivery of the prescription medication Orgovyx 120 mg tablet. The award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support the Department of Defense globally. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracts leverage Amerisourcebergen's extensive supply chain capabilities to efficiently deliver critical pharmaceutical and medical products to various government agencies and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 3/22/24 |